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Temporomandibular Joint, Diagnosis and Management of a 
Rare Tumor
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Abstract
The purpose of this paper was to describe a rare unusual case of 
primary mandibular condylar tenosynovial giant cell tumor of dif-
fuse type with predominantly intraosseous growth and its manage-
ment by resection and functional reconstruction with a vascularized 
costochondral graft. Clinical presentation was swelling in the right 
condylar area and limited mouth opening with radiological evidence 
of central bone destruction and magnetic resonance imaging showed 
central hemosiderin deposition. Fine needle aspiration did not lead 
to a diagnosis and an open biopsy had to be performed. Management 
consisted of tumor resection and reconstruction with a free vascular-
ized costochondral graft. Tenosynovial diffuse type giant cell tumor 
of the temporomandibular joint is very rare. Complete resection leads 
to a low recurrence rate and reconstruction with a costochondral free 
vascularized flap leads to an excellent functional outcome.
Keywords: Temporomandibular joint; Tenosynovial; Diffuse type 
giant cell tumor; Free vascularized graft; Costochondral graft; Re-
construction
Introduction
Tumors of the condyle or temporomandibular joint (TMJ) are 
rare [1-3]. Benign tumors such as chondroblastoma, osteoid 
osteoma, chondroma, osteoblastoma, osteoma or osteochon-
droma, are less common than malignancies such as either sar-
comas, metastases or other rare neoplasms [4-6].
Tenosynovial giant cell tumor (TSGT) occurs in two dif-
ferent clinical presentations: 1) a localized type on fingers and 
toes and 2) diffuse type (synonym pigmented villonodular 
synovitis (PVNS)) mostly around large joints. The diffuse type 
of TSGT is often intra-articular and shows infiltrative, often 
recurrent and occasionally destructive growth. Both types of 
TSGT are microscopically identical and overexpress colony 
stimulating factor (CSF) 1.
Tumors of the TMJ may initially follow an indolent course 
as a painless swelling that may become symptomatic with lim-
ited mouth opening as the tumors increase in size. Manage-
ment of the primary tumor mostly entails surgical excision and 
reconstructive management may vary from no replacement, 
free costocondral or other bone grafts, metal condyle, total 
joint replacement to free vascular graft replacement and osteo-
distraction [1, 7, 8]. Within the free vascular graft replacement 
options, the fibula is the most common free flap utilized for 
this purpose [9].
The purpose of this paper was to describe a rare unusual 
case of primary mandibular condylar TSGT of diffuse type 
of the TMJ with predominantly intraosseous growth and its 
management by resection and functional reconstruction with a 
vascularized costochondral graft.
Case Report
A 34-year-old, otherwise healthy Caucasian male patient was 
referred to our clinic with the complaint of swelling in the right 
TMJ for more than 2 years. The last few weeks before presen-
tation, the swelling, discomfort and limitation of mouth open-
ing increased significantly. No pain was present at rest or with 
mouth opening. Mouth opening was limited to an interincisal 
distance of 35 mm (Fig. 1). His personal medical history re-
vealed chronic bronchial asthma and periodic sinusitis and an 
inconspicuous family history.
On computer tomogram (CT) examination, a mixed radio-
lucent and radio-opaque tumor was seen that appeared as an 
enlarged condylar head (Fig. 2) and an interrupted cortical 
margin was evident, especially in the anterior aspect of the 
condyle. On MRI examination, a large inhomogeneous mass 
was seen expanding the condyle with cortical perforation in 
some areas and pronounced hemosiderin content (Fig. 3).
A benign tumor was considered as first option due to the 
slow growth pattern and fairly well demarcated tumor without 
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evidence of infiltration.
A transcutaneous fine needle aspiration (FNA) was per-
formed that led to a provisional diagnosis of a hemorrhagic, 
giant cell containing lesion with a comment that the precise 
diagnosis was unclear. Due to the predominantly intraosse-
ous growth, an osteoblastoma, an aneurysmal bone cyst and 
a brown tumor of hyperparathyroidism were considered in the 
differential diagnosis. Open biopsy followed via an intra-oral 
route to the anterior component of the condylar tumor with 
uneventful post-operative healing. Histopathological exami-
nation revealed myofibroblastic proliferation with a marked 
inflammatory component containing giant cells and abundant 
hemosiderin (Fig. 4) and the diagnosis of intraosseous growth 
of a TSGT of diffuse type was suggested. Although the main 
mass of the tumor was intraosseous, some extracortical com-
ponents could be verified on the pre-operative imaging (Fig. 
2, 3).
After discussing the treatment options in detail, the patient 
opted for our second choice, a free vascularized costochondral 
graft and decided against a custom total joint replacement. Ac-
cess to the tumor was via a pre-auricular and submandibular 
Figure 2. Coronal CT (bone window) depicts expansion of the right 
mandibular condyle by a soft tissue cancellous lesion with partial inter-
ruption of cortical bone and marked shortening of ascending ramus. 
Note lack of intraosseous trabeculae or calcification. 
Figure 3. Coronal MR (T2w) delineates an intraosseous soft tissue 
tumor with considerable intratumoral low signal (black color) indicat-
ing hemosiderin components. Articular surface of glenoid fossa is pre-
served. The joint capsule is markedly expanded. 
Figure 4. Histopathology: (A) Cut surface of the tumor, demonstrating 
locally destructive lesion with heterogeneous gross pattern. (B) Micro-
scopically, giant cells (arrows) containing proliferation of mononuclear 
cells with abundant brown hemosiderin pigment (hematoxylin and eo-
sin stain, original magnification × 200). 
Figure 1. Pre-operative view demonstrating limited mouth opening and 
swelling in the right temporomandibular joint area. 
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incision. After the low condylectomy bony incision the tumor 
was mobilized and removed laterally as well as inferiorly. Re-
moval of the antero-medial portion was difficult due to the at-
tachment of the lateral pterygoid muscle and a very brittle tu-
mor component in this area that resulted in removal in several 
fragments.
After tumor removal, the vascularized costochondral graft 
was harvested. The patient was partly positioned on his side 
(30°). The thoracodorsal artery was identified and followed 
until the branches to the serratus muscle. A 7 cm costochon-
dral graft of the seventh rib was raised, covered by the serratus 
muscle laterally and raised in a subperiosteal plain medially 
(Fig. 5).
The graft was positioned with lag screws and the occlu-
sion and mouth opening was checked. Vascular anastomosis 
followed with anastomosis on the superior thyroid artery and 
external jugular vein. One year post-operative follow-up MR 
(Fig. 6) depicted the total removal of the TGCT and a well 
remodeled bone graft adjacent to the glenoid fossa. Clinically 
the patient regained a normal, symmetrical mouth opening 
with translation movement on the right (Fig. 7).
Discussion
The World Health Organization distinguishes between two 
types of giant cell lesions originating from tendon and syn-
ovium, namely the localized giant cell tumor of tendon sheath 
that mostly appears in the flexor tendon sheaths of the hand 
and foot and the diffuse type giant cell tumor (GCT) that as the 
name depicts is a poorly defined soft tissue mass with a more 
aggressive growth pattern and associated high recurrence rate 
[10]. The latter, formerly often called PVNS, presents in larger 
joints like the hip and knee, although other joints may also 
be affected such as the ankles and shoulders and was first de-
scribed by Jaffe et al [11] An incidence of 2:1,000,000 per year 
is reported and presentation is mostly monoarticular with no 
sex predilection [12]. Presentation of this disease in the TMJ is 
extremely rare and so far less than 30 cases have been reported 
in the English literature [13].
First description of involvement of the TMJ was by Lapay-
owker et al in 1973, and since then 27 cases have been reported 
in the English literature [13, 14]. FNA has been described as a 
possible method of diagnosis by Tanaka et al; however, a suc-
cessful diagnosis in our case with FNA was not possible [15].
Clinical presentation is mostly a painless mass; however, 
trismus, pain, sensory disturbance and malocclusion have been 
described [13]. Our reported case corresponded with the typi-
cal findings of a painless mass and limited mouth opening.
Although this is a benign disease, more aggressive behav-
ior with intracranial extension of 22% or middle ear involve-
ment is possible [13, 16, 17]. Malignant forms are extremely 
rare with only around 30 cases being reported with only one af-
fecting the TMJ and associated with lung metastasis. It would 
appear as if malignant transformation of the benign lesions is 
possible [18]. General bone destruction is relatively common 
Figure 5. Vascularized costochondral graft and part serratus anterior 
muscle based on the thoraco-dorsal artery. 
Figure 6. Post-operative MR (T2w) 1 year following shows the costo-
chondral bone graft that due to remodeling abuts a well maintained joint 
space without evidence of recurrence. 
Figure 7. Post-operative view demonstrating improved mouth opening 
and condylar movement. 
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at a rate of 70.4% but primary intra-condylar manifestation of 
the disease is rare. The most common symptom appears to be 
swelling with late presentation of limited mouth opening and 
the duration of symptoms before presentation is on average 
11.5 months. Age of presentation is most common in the late 
thirties to late forties and a recurrence rate of 7.4% is reported 
without sex predilection [13].
Radiological features mainly constitute areas of bone de-
struction with cortical interruption with possible infiltration in 
the adjacent soft tissues on the computed tomogram. The joint 
space is often preserved until late in the disease process. Our 
described case had extensive primary intraosseous growth that 
is a more unusual finding (Fig. 2, 3). Low signal intensity in 
the T2w MR sequence is an indication of the hemosiderin con-
tent typical for this tumor. Differential diagnosis according to 
the radiological features may include other benign tumors of 
the condyle, or more widespread intra-articular lesions such 
as synovitis, synovial sarcoma, hemophilia, synovial heman-
gioma and synovial chondromatosis [17].
FNA cytological findings are distinctive enough to at least 
raise suspicion of the possible diagnosis in a typical presenta-
tion. It has been used in a number of cases to at least raise 
suspicion of the diagnosis, although the diagnosis can only 
be verified once the final histological specimen is examined 
[17, 19]. Diffuse type GCT histologically appears as a brown-
ish tumor with invasion of part or the complete synovium by 
capillary expansion. Synovial villous hypertrophy with foamy 
lipid or hemosiderin laden macrophage infiltration and multi-
ple multinucleated giant cells is evident on microscopy. The 
fibrotic stroma contains strands of collagen. Within the syno-
vial lining, hemosiderin may be located that may lead to the 
characteristic MRI findings and contribute to the characteristic 
brown color [16, 20].
Treatment is controversial owing to the heterogeneity and 
rarity of the disease. In the knee the treatment ranges from ar-
throscopy to complete surgical resection. In the extremities re-
currence rates of 25% and 50% in the intra- and extra-articular 
disease have been noted. Where complete surgical removal is 
not possible, radiotherapy has been utilized as sole treatment 
with a dose between 30 and 50 Gy. In cases of incomplete 
surgical removal radiation therapy as adjuvant therapy may 
be applied [20]. Due to CSF overexpression neo-adjuvant sys-
temic targeted therapy with imatinib or related tyrosine kinase 
inhibitors has also been advocated where the extremities have 
been affected and may be an option in disease affecting the 
TMJ. RANKLN antibody treatment may be another emerging 
treatment alternative [20].
In the TMJ most treatments consisted of wide resection 
with less than accurate data regarding the recurrence rate [15, 
21]. Radiotherapy should be reserved for irresectable tumors 
or where incomplete resection leaves residual disease and 
long-term follow-up of 5 - 7 years is recommended with cor-
responding CT or MRI to rule out recurrence of this rare tumor 
[13].
Conclusion
Tenosynovial, diffuse type giant cell tumor of the TMJ is a 
rare tumor with characteristic radiological and histological 
features. It requires complete resection and close follow-up to 
rule out recurrence. Reconstruction with a vascularized cos-
tochondral graft seems to offer an excellent functional recon-
structive option after ablative surgery of the TMJ.
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